Omeros (OMER) Current Assets (2010 - 2026)
Omeros recorded quarterly Current Assets of $180.4 million in Q1 2026, down 16.37% quarter-over-quarter from $215.7 million in Q4 2025, and up 87.52% year-over-year from $96.2 million in Q1 2025.
Omeros' Current Assets history runs 17 years deep, the most recent figure standing at $180.4 million for Q1 2026.
- In Q1 2026, Current Assets rose 87.52% year-over-year to $180.4 million; the TTM figure through Mar 2026 stood at $180.4 million (up 87.52% YoY), while the FY2025 annual figure was $215.7 million, up 60.8% from the prior year.
- Current Assets came in at $180.4 million for Q1 2026 at Omeros, down from $215.7 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $443.2 million in Q4 2022 to a low of $69.6 million in Q2 2025.
- A 5-year average of $230.9 million and a median of $210.2 million in 2022 frame the typical range for Current Assets.
- Across the five-year window, Current Assets soared 215.87% in 2022 and tumbled 65.77% in 2025, its largest moves.
- Omeros' Current Assets stood at $443.2 million in 2022, then slumped by 50.84% to $217.9 million in 2023, then slumped by 38.45% to $134.1 million in 2024, then soared by 60.8% to $215.7 million in 2025, then slipped by 16.37% to $180.4 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $180.4 million, $215.7 million, and $71.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.21 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 180.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 180.36 Mn |
| Dec 31, 2025 | 215.67 Mn |
| Sep 30, 2025 | 71.81 Mn |
| Jun 30, 2025 | 69.65 Mn |
| Mar 31, 2025 | 96.18 Mn |
| Dec 31, 2024 | 134.12 Mn |
| Sep 30, 2024 | 164.92 Mn |
| Jun 30, 2024 | 202.93 Mn |
| Mar 31, 2024 | 280.96 Mn |
| Dec 31, 2023 | 217.90 Mn |
| Sep 30, 2023 | 351.34 Mn |
| Jun 30, 2023 | 388.56 Mn |
| Mar 31, 2023 | 417.04 Mn |
| Dec 31, 2022 | 443.24 Mn |
| Sep 30, 2022 | 288.55 Mn |
| Jun 30, 2022 | 192.72 Mn |
| Mar 31, 2022 | 210.22 Mn |
| Dec 31, 2021 | 247.96 Mn |
| Sep 30, 2021 | 91.35 Mn |
| Jun 30, 2021 | 112.40 Mn |
| Mar 31, 2021 | 132.48 Mn |
| Dec 31, 2020 | 151.29 Mn |
| Sep 30, 2020 | 195.99 Mn |
| Jun 30, 2020 | 38.93 Mn |
| Mar 31, 2020 | 85.61 Mn |
| Dec 31, 2019 | 103.75 Mn |
| Sep 30, 2019 | 63.80 Mn |
| Jun 30, 2019 | 65.94 Mn |
| Mar 31, 2019 | 76.87 Mn |
| Dec 31, 2018 | 89.87 Mn |
| Sep 30, 2018 | 66.00 Mn |
| Jun 30, 2018 | 96.50 Mn |
| Mar 31, 2018 | 78.68 Mn |
| Dec 31, 2017 | 108.37 Mn |
| Sep 30, 2017 | 117.90 Mn |
| Jun 30, 2017 | 53.09 Mn |
| Mar 31, 2017 | 51.35 Mn |
| Dec 31, 2016 | 60.26 Mn |
| Sep 30, 2016 | 60.65 Mn |
| Jun 30, 2016 | 34.11 Mn |
| Mar 31, 2016 | 24.32 Mn |
| Dec 31, 2015 | 37.15 Mn |
| Sep 30, 2015 | 39.46 Mn |
| Jun 30, 2015 | 56.68 Mn |
| Mar 31, 2015 | 73.07 Mn |
| Dec 31, 2014 | 9.04 Mn |
| Sep 30, 2014 | 23.36 Mn |
| Jun 30, 2014 | 38.97 Mn |
| Mar 31, 2014 | 54.13 Mn |
| Dec 31, 2013 | 14.82 Mn |
| Sep 30, 2013 | 10.27 Mn |
| Jun 30, 2013 | 21.27 Mn |
| Mar 31, 2013 | 15.81 Mn |
| Dec 31, 2012 | 24.70 Mn |
| Sep 30, 2012 | 31.44 Mn |
| Jun 30, 2012 | 8.52 Mn |
| Mar 31, 2012 | 19.70 Mn |
| Dec 31, 2011 | 25.95 Mn |
| Sep 30, 2011 | 33.84 Mn |
| Jun 30, 2011 | 39.67 Mn |
| Dec 31, 2010 | 43.75 Mn |